Our result from the up‐regulated PD‐L1 in cisplatin‐resistant HNSCC cells provided evidences that PD‐L1 in tumor cells is associated with the enhancing aggressive characteristics of HNSCC cells, including resistance to chemotherapeutic drug. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.